Clinical Evaluation of the TITAN™ Total Shoulder System

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-03-20

Study Completion Date

2022-06-23

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A post market, non-randomized, multi-center, open-label,clinical study using survivorship to study the safety and efficacy of the Integra® TITAN™ Total Shoulder System 1.0 (TAS) when used for total shoulder arthroplasty.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Short-Term Outcomes of Total Shoulder Arthroplasty Using the Titan Modular Total Shoulder System

NCT03956316

Shoulder Disease

COMPLETED

REGENETEN™ Bioinductive Implant System in Full-thickness Tears

NCT04450342

Rotator Cuff Injuries

TERMINATED NA

Safety and Effectiveness of the Tornier Simpliciti™ Shoulder System in Shoulder Arthroplasty

NCT02452957

Shoulder Osteoarthritis

WITHDRAWN

A Post-Market Clinical Evaluation of the ReUnion Reverse Shoulder Arthroplasty (RSA) System

NCT03880955

Shoulder Arthroplasty

TERMINATED

Catalyst CSR Shoulder System for Semi or Total Shoulder Arthroplasty

NCT04968405

Osteoarthritis Shoulder Avascular Necrosis of the Head of Humerus Rheumatoid Arthritis Shoulder

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Observational, multi-center, post-market study to provide data on the performance and safety of the TITAN™ Total Shoulder System. The study will enroll patients that underwent total shoulder arthroplasty with the TITAN™ Total Shoulder System per standard of care less than 5 years ago. Available retrospective data up to the 2-year time point will be collected, per the study protocol, from medical record reviews. Prospective observational data will be collected from the time of patient enrollment during the following postoperative clinical visits: 1 year, 2 years, 5 years and 10 years post-surgery.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Arthritis Arthritis, Degenerative Rheumatoid Arthritis Post-traumatic Arthrosis of Other Joints, Shoulder Region Rotator Cuff Syndrome of Shoulder and Allied Disorders Fracture Avascular Necrosis Joint Instability Joint Trauma Dislocation, Shoulder Pain, Shoulder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

TITAN™ Total Shoulder System Generation 1.0

Integra TITAN™ Total Shoulder System Generation 1.0

Integra TITAN™ Total Shoulder Generation 1.0

Intervention Type DEVICE

Total Shoulder Arthroplasty or Hemiarthroplasty

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Integra TITAN™ Total Shoulder Generation 1.0

Total Shoulder Arthroplasty or Hemiarthroplasty

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Subject has undergone shoulder arthroplasty with the first generation TITAN Total Shoulder System.
2. The first generation TITAN Total Shoulder System is still intact and the subject has not received any revision surgeries involving the TITAN Total Shoulder System.
3. Subject is willing and able to participate in required follow-up visits at the investigational site and to complete study procedures.

Exclusion Criteria

1. Subject, in the opinion of the PI, has an emotional or neurological condition that would pre-empt their ability or willingness to participate in the study such as mental illness, or drug or alcohol abuse.
2. Subject is known to be at risk for lost to follow-up, or failure to return for scheduled visits.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No